Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael F Marmor

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
JAMA Ophthalmology|June 4, 2016
Update on Screening Recommendations for Hydroxychloroquine RetinopathyJudy E Kim, Michael F Marmor
Survey of Ophthalmology|May 15, 2003
Escher and the ophthalmologistMichael F Marmor, Willem A Wagenaar
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 13, 2011
Fluorescein angiography: insight and serendipity a half century agoMichael F Marmor, James G Ravin
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2010
Simulating vision with and without macular diseaseDavid J Marmor, Michael F Marmor
JAMA Ophthalmology|October 3, 2014
The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapyRonald B Melles, Michael F Marmor
Ophthalmology|January 21, 2014
Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathyMichael F Marmor, Ronald B Melles
Documenta Ophthalmologica. Advances in Ophthalmology|August 3, 2002
Effects of pre-adaptation conditions and ambient room lighting on the multifocal ERGAimee V Chappelow, Michael F Marmor
Ophthalmology|May 14, 2022
Rapid Macular Thinning Is an Early Indicator of Hydroxychloroquine Retinal ToxicityRonald B Melles, Michael F Marmor
Ophthalmology|September 4, 2014
Pericentral retinopathy and racial differences in hydroxychloroquine toxicityRonald B Melles, Michael F Marmor
Documenta Ophthalmologica. Advances in Ophthalmology|April 29, 2017
ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosaArchana A Nair, Michael F Marmor
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
JAMA Ophthalmology|June 4, 2016
Update on Screening Recommendations for Hydroxychloroquine RetinopathyJudy E Kim, Michael F Marmor
Survey of Ophthalmology|May 15, 2003
Escher and the ophthalmologistMichael F Marmor, Willem A Wagenaar
Archives of Ophthalmology (Chicago, Ill. : 1960)|July 13, 2011
Fluorescein angiography: insight and serendipity a half century agoMichael F Marmor, James G Ravin
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 13, 2010
Simulating vision with and without macular diseaseDavid J Marmor, Michael F Marmor
JAMA Ophthalmology|October 3, 2014
The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapyRonald B Melles, Michael F Marmor
Ophthalmology|January 21, 2014
Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathyMichael F Marmor, Ronald B Melles
Documenta Ophthalmologica. Advances in Ophthalmology|August 3, 2002
Effects of pre-adaptation conditions and ambient room lighting on the multifocal ERGAimee V Chappelow, Michael F Marmor
Ophthalmology|May 14, 2022
Rapid Macular Thinning Is an Early Indicator of Hydroxychloroquine Retinal ToxicityRonald B Melles, Michael F Marmor
Ophthalmology|September 4, 2014
Pericentral retinopathy and racial differences in hydroxychloroquine toxicityRonald B Melles, Michael F Marmor
Documenta Ophthalmologica. Advances in Ophthalmology|April 29, 2017
ERG and other discriminators between advanced hydroxychloroquine retinopathy and retinitis pigmentosaArchana A Nair, Michael F Marmor
Pageof 12